New Delhi: The Delhi High Court has reportedly asked the union government to explain its position and actions of issuing the March 10 notification banning 344 fixed dose combination drugs in India.
The court has also stayed the notification with respect to three pharma companies – Pfizer, Abbott and MacLeod, which had challenged the government’s order in the court — until next hearing on March 21.
The pharma companies argued that despite the products being in the market for a number of years, the government had not granted a show cause notice to seek explanation.
However, the government clarified that since this is a matter of public interest, it was not obliged to serve a show cause notice or seek explanation from pharma companies, reports Money Control.
(Read the March 10 Notification issued by the Union Ministry of Health And Family Welfare)